PL371630A1 - Podstawione pochodne aminoizoksazoliny i ich zastosowanie jako środki przeciwdepresyjne - Google Patents

Podstawione pochodne aminoizoksazoliny i ich zastosowanie jako środki przeciwdepresyjne

Info

Publication number: PL371630A1
Authority: PL; Poland
Prior art keywords: depressants; substituted amino; isoxazoline derivatives; amino isoxazoline; derivatives
Prior art date: 2002-04-02

Application number

PL03371630A

Other languages

English (en)

Other versions

PL211708B1 (pl

Inventor

Jose Ignacio Andres-Gil

Manuel Jesus Alcazar-Vaca

Margaretha Henrica Maria Bakker

Lucas Olivares Ana Isabel De

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-02

Filing date

2003-03-27

Publication date

2005-06-27

2003-03-27 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

2005-06-27 Publication of PL371630A1 publication Critical patent/PL371630A1/pl

2012-06-29 Publication of PL211708B1 publication Critical patent/PL211708B1/pl

Links

XPZOKPQZEPSMFC-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazol-3-amine Chemical class NC1=NOCC1 XPZOKPQZEPSMFC-UHFFFAOYSA-N 0.000 title 1
230000001430 anti-depressive effect Effects 0.000 title 1
239000000935 antidepressant agent Substances 0.000 title 1
229940005513 antidepressants Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Addiction (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

PL371630A 2002-04-02 2003-03-27 Pochodne aminoizoksazoliny, sposób ich otrzymywania, kompozycja je zawierająca oraz ich zastosowanie PL211708B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02076239		2002-04-02

Publications (2)

Publication Number	Publication Date
PL371630A1 true PL371630A1 (pl)	2005-06-27
PL211708B1 PL211708B1 (pl)	2012-06-29

Family

ID=28459528

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL371630A PL211708B1 (pl)	2002-04-02	2003-03-27	Pochodne aminoizoksazoliny, sposób ich otrzymywania, kompozycja je zawierająca oraz ich zastosowanie

Country Status (24)

Country	Link
US (1)	US7265103B2 (pl)
EP (1)	EP1492796B1 (pl)
JP (1)	JP4580653B2 (pl)
KR (1)	KR20040093061A (pl)
CN (1)	CN100349897C (pl)
AR (1)	AR039207A1 (pl)
AT (1)	ATE372342T1 (pl)
BR (1)	BR0308309A (pl)
CA (1)	CA2480113C (pl)
DE (1)	DE60316134T2 (pl)
DK (1)	DK1492796T3 (pl)
EA (1)	EA008189B1 (pl)
ES (1)	ES2292949T3 (pl)
HK (1)	HK1080072A1 (pl)
HR (1)	HRP20040871A2 (pl)
IL (2)	IL164341A0 (pl)
MX (1)	MXPA04008626A (pl)
NO (1)	NO20044645L (pl)
NZ (1)	NZ536109A (pl)
PL (1)	PL211708B1 (pl)
PT (1)	PT1492796E (pl)
TW (1)	TWI286138B (pl)
WO (1)	WO2003082878A1 (pl)
ZA (1)	ZA200407904B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR040967A1 (es)	2002-08-12	2005-04-27	Janssen Pharmaceutica Nv	Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
DE60319388T2 (de) *	2002-08-21	2009-02-19	Janssen Pharmaceutica N.V.	C6- und C9-substituierte Chromeno[4,3-c]Isoxazoline und ihre Verwendung als Anti-Depressiva
ES2331144T3 (es)	2004-11-26	2009-12-22	Janssen Pharmaceutica Nv	Derivados de isoxazolina-indol con actividad antipsicotica y ansiolitica mejorada.
BRPI0812833A2 (pt) *	2007-07-03	2014-12-09	Hoffmann La Roche	4-imidazolinas e seu uso como antidepressivos
KR20110128913A (ko)	2009-03-10	2011-11-30	다케다 야쿠힌 고교 가부시키가이샤	벤조푸란 유도체
US20130062732A1 (en)	2011-09-08	2013-03-14	International Business Machines Corporation	Interconnect structures with functional components and methods for fabrication
CN105801510A (zh) *	2016-04-08	2016-07-27	李勇	一种治疗抑郁症的药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0361577B1 (en)	1988-09-19	1993-05-05	Akzo N.V.	Tetrahydronaphthalene and indane derivatives
AU710059B2 (en) *	1996-01-05	1999-09-09	Aventis Pharmaceuticals Inc.	4,5-dihydronaphth(1,2-C)isoxazoles and derivatives thereof having CNS activity
US6187774B1 (en)	1996-03-04	2001-02-13	Yoshitomi Pharmaceutical Industries, Ltd.	Fused heterocyclic compounds and pharmaceutical applications thereof
HUP0303270A3 (en) *	2001-02-21	2007-03-28	Janssen Pharmaceutica Nv	Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them
AR040967A1 (es) *	2002-08-12	2005-04-27	Janssen Pharmaceutica Nv	Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
DE60319388T2 (de) *	2002-08-21	2009-02-19	Janssen Pharmaceutica N.V.	C6- und C9-substituierte Chromeno[4,3-c]Isoxazoline und ihre Verwendung als Anti-Depressiva

2003
- 2003-03-27 ES ES03714897T patent/ES2292949T3/es not_active Expired - Lifetime
- 2003-03-27 WO PCT/EP2003/003245 patent/WO2003082878A1/en not_active Ceased
- 2003-03-27 NZ NZ536109A patent/NZ536109A/en unknown
- 2003-03-27 PL PL371630A patent/PL211708B1/pl unknown
- 2003-03-27 DE DE60316134T patent/DE60316134T2/de not_active Expired - Lifetime
- 2003-03-27 EP EP03714897A patent/EP1492796B1/en not_active Expired - Lifetime
- 2003-03-27 AT AT03714897T patent/ATE372342T1/de not_active IP Right Cessation
- 2003-03-27 HR HR20040871A patent/HRP20040871A2/hr not_active Application Discontinuation
- 2003-03-27 IL IL16434103A patent/IL164341A0/xx unknown
- 2003-03-27 HK HK05112213.1A patent/HK1080072A1/zh unknown
- 2003-03-27 BR BR0308309-8A patent/BR0308309A/pt not_active IP Right Cessation
- 2003-03-27 CA CA2480113A patent/CA2480113C/en not_active Expired - Fee Related
- 2003-03-27 JP JP2003580343A patent/JP4580653B2/ja not_active Expired - Fee Related
- 2003-03-27 US US10/510,220 patent/US7265103B2/en not_active Expired - Lifetime
- 2003-03-27 EA EA200401297A patent/EA008189B1/ru not_active IP Right Cessation
- 2003-03-27 KR KR10-2004-7012757A patent/KR20040093061A/ko not_active Ceased
- 2003-03-27 MX MXPA04008626A patent/MXPA04008626A/es active IP Right Grant
- 2003-03-27 PT PT03714897T patent/PT1492796E/pt unknown
- 2003-03-27 CN CNB038074192A patent/CN100349897C/zh not_active Expired - Fee Related
- 2003-03-27 DK DK03714897T patent/DK1492796T3/da active
- 2003-04-01 AR ARP030101126A patent/AR039207A1/es unknown
- 2003-04-01 TW TW092107328A patent/TWI286138B/zh not_active IP Right Cessation
2004
- 2004-09-28 IL IL164341A patent/IL164341A/en not_active IP Right Cessation
- 2004-09-30 ZA ZA200407904A patent/ZA200407904B/xx unknown
- 2004-10-27 NO NO20044645A patent/NO20044645L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1492796B1 (en)	2007-09-05
AU2003219111A1 (en)	2003-10-13
MXPA04008626A (es)	2004-12-06
CA2480113C (en)	2012-04-24
TWI286138B (en)	2007-09-01
NZ536109A (en)	2006-06-30
PL211708B1 (pl)	2012-06-29
TW200406414A (en)	2004-05-01
EA008189B1 (ru)	2007-04-27
KR20040093061A (ko)	2004-11-04
NO20044645L (no)	2004-10-27
HRP20040871A2 (en)	2005-04-30
DE60316134T2 (de)	2008-05-29
US7265103B2 (en)	2007-09-04
IL164341A (en)	2009-06-15
AR039207A1 (es)	2005-02-09
BR0308309A (pt)	2004-12-28
CN1642960A (zh)	2005-07-20
HK1080072A1 (zh)	2006-04-21
JP2005522469A (ja)	2005-07-28
WO2003082878A1 (en)	2003-10-09
ATE372342T1 (de)	2007-09-15
PT1492796E (pt)	2007-11-16
IL164341A0 (en)	2005-12-18
EA200401297A1 (ru)	2005-02-24
US20050222125A1 (en)	2005-10-06
EP1492796A1 (en)	2005-01-05
ES2292949T3 (es)	2008-03-16
CA2480113A1 (en)	2003-10-09
ZA200407904B (en)	2005-10-20
CN100349897C (zh)	2007-11-21
DE60316134D1 (de)	2007-10-18
DK1492796T3 (da)	2007-12-03
JP4580653B2 (ja)	2010-11-17

Legal Events

Date	Code	Title	Description
2012-12-31	RECP	Rectifications of patent specification

Publication	Publication Date	Title
IL173726A0 (en)	2006-07-05	N,n-dihalogenated amino acids and derivatives
PT2702871T (pt)	2019-02-01	Biotecido de colagénio e sua utilização
PL370766A1 (pl)	2005-05-30	Podstawione 2-aminocykloalkanokarboksyamidy i ichzastosowanie jako inhibitorów proteaz cysteinowych
AU2003254844A1 (en)	2004-02-25	Substituted amino compounds and use thereof
EP1596808A4 (en)	2007-04-04	L-DOPA AMID DERIVATIVES AND THEIR USE
IL168747A0 (en)	2009-02-11	Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
IL163868A0 (en)	2005-12-18	Hermiasterlin derivatives and uses thereof
EG25683A (en)	2012-05-16	Benzoxazine derivatives and uses thereof
PL375195A1 (pl)	2005-11-28	Pochodne aminoalkoholi
PL377770A1 (pl)	2006-02-20	Podstawione benzoksazynony i ich zastosowanie
IL174479A0 (en)	2006-08-01	Hemiasterlin derivatives and uses thereof
ZA200604725B (en)	2007-12-27	Benzoxazine derivatives and uses thereof
SI1551805T1 (sl)	2013-07-31	Substituirani gama-fenil-delta-laktami in njihova uporaba
IL166821A0 (en)	2006-01-15	Novel 1,4-diazabicycloalkane derivatives their preparation and use
SI1368358T1 (sl)	2007-02-28	Izoksazolinski derivati kot antidepresivi
AU2003268075A8 (en)	2004-02-25	Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
IL164341A0 (en)	2005-12-18	Substituted amino isoxazoline derivatives and their use as anti-depressants
AU2003231827A8 (en)	2003-12-12	Pseudo-tissues and uses thereof
GB2409796B (en)	2006-06-07	Composition comprising proteinaceous material, its preparation and use
GB0316910D0 (en)	2003-08-20	Fluorocombretastatin and derivatives thereof
PL1786759T3 (pl)	2012-11-30	Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
GB0317376D0 (en)	2003-08-27	Immunogenic protein and uses thereof
GB0307231D0 (en)	2003-04-30	7-Nitroindoline derivatives and their uses
EP1699809A4 (en)	2009-10-21	PEPTIDE FROM AMNIOTIC LIQUID AND USES THEREOF
EP1499338A4 (en)	2008-06-18	7-HYDROXY-16ALPHA-FLUORO-5-ANDROSENES-17-ONE AND 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSTAN-17-ONE AND THEIR DERIVATIVES